Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 22/11/23 → 21/11/25 |
Keywords
- Clinical trial
- MK-4280A-010
Clinical Trial Phase
- Phase II
A Multicenter, Randomized, DoubleBlind, Phase 2, Basket Study of MK-4280A, a Coformulation of Favezelimab (MK-4280) with Pembrolizumab (MK-3475) in Selected Solid Tumors (KeyForm-010)
- Voskoboynik, Mark (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research